MedTrace Logo

Letrozole in Induction of Abortion of Anembryonic Pregnancy

NCT05198050 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2023-09-11

No results posted yet for this study

Summary

Some studies suggest the prescription of aromatase inhibitors prior to the use of misoprostol for inducing drug abortion. the aim of the study is to compare the effectiveness of various regimens of letrozole combined with misoprostol versus using misoprostol alone in inducing complete abortion in patients with blighted ovum.

Conditions

  • Anembryonic Pregnancy

Interventions

DRUG

Letrozole tablets

Letrozole is a third-generation non-steroidal aromatase inhibitor

DRUG

Misoprostol Tabets

a synthetic prostaglandin medication

DRUG

Placebo tablets

Placebo tables with a similar appearance to letrozole

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Marwa M Abdalla, MD · Kasralainy teaching hospital

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-03
Primary Completion
2022-09-30
Completion
2022-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05198050 on ClinicalTrials.gov